Study of Occipital Nerve Stimulation

February 13, 2007

Medtronic Begins Study of Occipital Nerve Stimulation for Chronic, Refractory Migraine Headaches; Implanted Device Delivers Electrical Impulses to Occipital Nerves. Medtronic Begins Study of Occipital Nerve Stimulation for Chronic, Refractory Migraine Headaches; Implanted Device Delivers Electrical Impulses to Occipital Nerves

Medtronic, Inc. today announced the first patient implant in a preliminary study to evaluate if an implanted device might help some of the thousands of Americans who suffer the agony of chronic migraine headaches that have not responded to other treatments.

More on occipital nerve block: The current issue of journal Headache presents a report of two patients whose prolonged hemiplegic migraine aura resolved with greater occipital nerve block. It is hard to explain how blocking a nerve would stop this brain dysfunction, but Botox which we routinely use to treat migraines, also seems to affect brain processes through peripheral nerves. I might try occipital nerve block for my next patient with a prolonged aura, but only if an intravenous infusion of one gram of magnesium sulfate fails.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe